Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
Abroad (travel likely)RecruitingPHASE2
Conditions
Acute Myeloid Leukemia, Relapsed, Adult · Acute Myeloid Leukemia Refractory · Chronic Myeloid Leukemia - Accelerated Phase · Myelodysplastic Syndromes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Illinois Cancer Center, Chicago, Illinois, United States
Study leads
Matias Sanchez, MD
Principal Investigator
University of Illinois at Chicago